Tech News Summary:
- Aberdeen Royal Infirmary is testing artificial intelligence to help radiologists review mammograms and detect early-stage breast cancer.
- The Mia AI model developed by Kheiron Medical Technologies was used in the trial, while Microsoft provided cloud computing services to support it.
- The decline in “super reader” radiologists and the potential for AI to cover half of the detection image reading load highlights the importance of AI in helping doctors save lives, but Dr Gerald Lip believes it should be used to work with human staff rather than replace them.
Aberdeen, Scotland – A revolutionary artificial intelligence (AI) trial in Scotland has been successful in transforming the way doctors diagnose breast cancer. This ground-breaking project has been developed by researchers from the University of Aberdeen, in partnership with NHS Greater Glasgow and Clyde, as part of a wider initiative to benefit the healthcare system across the UK.
The trial, which has been ongoing since April of this year, has been testing AI computer programs to identify the early signs of breast cancer. Using scans and data from mammograms, the AI has been able to identify potential tumors that may have been missed by human radiologists. The AI has had a high success rate and proved more accurate than human assessment in some cases.
Speaking about the trial, Dr. David Greenberg, project lead and senior research fellow in Aberdeen, explained: “Our AI system is learning to identify subtle changes in breast tissue that can help identify cancerous growths earlier. We hope this technology will enable medical professionals to diagnose cancerous growths more accurately, which will ultimately lead to better patient care.”
The use of AI in breast cancer diagnosis is not new, but the trial in Aberdeen utilizes a more advanced image recognition system than previous trials. The technology has the potential to transform cancer diagnosis, not just in the UK but globally. This is great news for medical professionals and patients alike, as earlier identification and diagnosis of cancer can greatly increase the chances of successful treatment.
Commenting on the success of the trial, Professor Sir Ian Diamond, the UK’s National Statistician, said: “This project is an example of how data and systems thinking can revolutionize cancer treatment, delivering more accurate and faster diagnoses while improving patient care. The UK’s ambition is to become a global leader in AI, and this trial shows the tremendous potential for the technology in healthcare.”
With the success of the trial, the University of Aberdeen and NHS Greater Glasgow and Clyde are now exploring further applications for the project, as well as ways to integrate AI into the wider healthcare system. The possibilities for AI are endless, and this trial is just one of many steps towards revolutionizing healthcare diagnosis and treatment.